Education
About Us
Working with TipRanks
Follow Us
Inovio Pharmaceuticals (INO)
NASDAQ:INO
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 217.76K | $ 832.01K | $ 10.26M | $ 1.77M |
| Gross Profit | $ 0.00 | $ 217.76K | $ 832.01K | $ 10.26M | $ 1.77M |
| Operating Income | $ -86.82B | $ -112.40M | $ -143.94M | $ -267.57M | $ -301.22M |
| EBITDA | $ -86.82B | $ -103.95M | $ -130.39M | $ -270.90M | $ -296.56M |
| Net Income | $ -84.95B | $ -107.25M | $ -135.12M | $ -279.82M | $ -303.66M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 58.51B | $ 94.11M | $ 145.29M | $ 253.00M | $ 401.31M |
| Total Assets | $ 74.31B | $ 113.20M | $ 170.95M | $ 348.53M | $ 495.94M |
| Total Debt | $ 9.37B | $ 11.87M | $ 30.21M | $ 32.07M | $ 33.02M |
| Net Debt | $ -34.91B | $ -53.95M | $ 15.90M | $ -14.25M | $ -38.12M |
| Total Liabilities | $ 50.21B | $ 44.69M | $ 53.60M | $ 126.17M | $ 96.27M |
| Stockholders' Equity | $ 24.10B | $ 68.50M | $ 117.35M | $ 222.36M | $ 399.67M |
| Cash Flow | |||||
| Free Cash Flow | $ -88.63B | $ -104.56M | $ -124.69M | $ -217.18M | $ -216.94M |
| Operating Cash Flow | $ -88.63B | $ -104.08M | $ -124.37M | $ -216.22M | $ -215.71M |
| Investing Cash Flow | $ 14.04B | $ 104.07M | $ 87.36M | $ 109.59M | $ -175.34M |
| Financing Cash Flow | $ 53.05B | $ 51.48M | $ 5.00M | $ 81.84M | $ 211.50M |